- Home
- NEOV vs LFCR Comparison
NEOV vs LFCR Comparison
Compare NEOV & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- LFCR
- Stock Information
- Founded
- NEOV 2018
- LFCR 1986
- Country
- NEOV United States
- LFCR United States
- Employees
- NEOV N/A
- LFCR N/A
- Industry
- NEOV Industrial Machinery/Components
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- NEOV Miscellaneous
- LFCR Health Care
- Exchange
- NEOV Nasdaq
- LFCR Nasdaq
- Market Cap
- NEOV 181.8M
- LFCR 214.7M
- IPO Year
- NEOV N/A
- LFCR N/A
- Fundamental
- Price
- NEOV $3.32
- LFCR $5.94
- Analyst Decision
- NEOV Strong Buy
- LFCR Buy
- Analyst Count
- NEOV 1
- LFCR 3
- Target Price
- NEOV $7.50
- LFCR $8.00
- AVG Volume (30 Days)
- NEOV 314.7K
- LFCR 239.5K
- Earning Date
- NEOV 02-11-2025
- LFCR 01-02-2025
- Dividend Yield
- NEOV N/A
- LFCR N/A
- EPS Growth
- NEOV N/A
- LFCR N/A
- EPS
- NEOV N/A
- LFCR N/A
- Revenue
- NEOV $2,471,178.00
- LFCR $130,858,000.00
- Revenue This Year
- NEOV $85.10
- LFCR $2.24
- Revenue Next Year
- NEOV $281.25
- LFCR $7.88
- P/E Ratio
- NEOV N/A
- LFCR N/A
- Revenue Growth
- NEOV N/A
- LFCR 16.47
- 52 Week Low
- NEOV $0.63
- LFCR $3.68
- 52 Week High
- NEOV $6.11
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- NEOV 37.59
- LFCR 37.34
- Support Level
- NEOV $3.15
- LFCR $5.80
- Resistance Level
- NEOV $3.85
- LFCR $6.20
- Average True Range (ATR)
- NEOV 0.33
- LFCR 0.28
- MACD
- NEOV -0.05
- LFCR -0.04
- Stochastic Oscillator
- NEOV 18.12
- LFCR 6.40
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.